Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

NCT03725033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

538

Enrollment

INDUSTRY

Sponsor class

Conditions

Impaired Glucose Tolerance

Interventions

DRUG: Subetta
DRUG: Placebo

Sponsor

Materia Medica Holding